PL371098A1 - Kombinacje zawierające pochodne epotilonu i środki alkilujące - Google Patents

Kombinacje zawierające pochodne epotilonu i środki alkilujące

Info

Publication number
PL371098A1
PL371098A1 PL03371098A PL37109803A PL371098A1 PL 371098 A1 PL371098 A1 PL 371098A1 PL 03371098 A PL03371098 A PL 03371098A PL 37109803 A PL37109803 A PL 37109803A PL 371098 A1 PL371098 A1 PL 371098A1
Authority
PL
Poland
Prior art keywords
combinations
alkylating agents
epothilone derivatives
hydrogen
lower alkyl
Prior art date
Application number
PL03371098A
Other languages
English (en)
Inventor
Judith Rose Anderson
John David Rothermel
Sheehy Paul M.J. Mc
Alan Boddy
Original Assignee
Novartis Ag
University Of Newcastle Upon Tyne
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag, University Of Newcastle Upon Tyne filed Critical Novartis Ag
Publication of PL371098A1 publication Critical patent/PL371098A1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Silicon Polymers (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL03371098A 2002-03-08 2003-03-07 Kombinacje zawierające pochodne epotilonu i środki alkilujące PL371098A1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US36273802P 2002-03-08 2002-03-08

Publications (1)

Publication Number Publication Date
PL371098A1 true PL371098A1 (pl) 2005-06-13

Family

ID=27805222

Family Applications (1)

Application Number Title Priority Date Filing Date
PL03371098A PL371098A1 (pl) 2002-03-08 2003-03-07 Kombinacje zawierające pochodne epotilonu i środki alkilujące

Country Status (22)

Country Link
EP (1) EP1485090B1 (pl)
JP (1) JP2005522461A (pl)
KR (1) KR20040101274A (pl)
CN (2) CN100402029C (pl)
AT (1) ATE375157T1 (pl)
AU (1) AU2003223958B2 (pl)
BR (1) BR0308258A (pl)
CA (1) CA2478223C (pl)
CY (1) CY1107126T1 (pl)
DE (1) DE60316775T2 (pl)
DK (1) DK1485090T3 (pl)
ES (1) ES2295575T3 (pl)
HU (1) HUP0500092A2 (pl)
IL (3) IL163774A0 (pl)
MX (1) MXPA04008707A (pl)
NO (1) NO20044208L (pl)
NZ (1) NZ535081A (pl)
PL (1) PL371098A1 (pl)
PT (1) PT1485090E (pl)
RU (1) RU2341260C2 (pl)
WO (1) WO2003075899A2 (pl)
ZA (1) ZA200406790B (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2273083C (en) 1996-12-03 2012-09-18 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereto, analogues and uses thereof
US8536188B2 (en) * 2007-04-25 2013-09-17 Cyclacel Limited Dosing regimens for treatment of proliferative disorders comprising administration of sapacitabine
US20110300150A1 (en) 2010-05-18 2011-12-08 Scott Eliasof Compositions and methods for treatment of autoimmune and other disease

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6515016B2 (en) * 1996-12-02 2003-02-04 Angiotech Pharmaceuticals, Inc. Composition and methods of paclitaxel for treating psoriasis
JP2001513098A (ja) * 1997-02-25 2001-08-28 ゲゼルシャフト フュア バイオテクノロギッシェ フォーシュンク エム ベー ハー（ゲー ベー エフ） 側鎖を修飾したエポチロン
US6320045B1 (en) * 1997-12-04 2001-11-20 Bristol-Myers Squibb Company Process for the reduction of oxiranyl epothilones to olefinic epothilones
EP1051490A2 (en) * 1998-01-30 2000-11-15 Cold Spring Harbor Laboratory Modulation of cell proliferation, methods and reagents
CZ301498B6 (cs) * 1999-02-22 2010-03-24 Gesellschaft Fuer Biotechnologische Forschung Mbh (Gbf) C-21 modifikované epothilony
UA75365C2 (en) * 2000-08-16 2006-04-17 Bristol Myers Squibb Co Epothilone analog polymorph modifications, a method for obtaining thereof (variants), a pharmaceutical composition based thereon

Also Published As

Publication number Publication date
ATE375157T1 (de) 2007-10-15
MXPA04008707A (es) 2006-03-08
IL163774A (en) 2010-12-30
WO2003075899A2 (en) 2003-09-18
ZA200406790B (en) 2006-05-31
IL163774A0 (en) 2005-12-18
WO2003075899A3 (en) 2004-03-11
RU2004130283A (ru) 2005-08-10
BR0308258A (pt) 2005-01-04
IL188859A0 (en) 2008-04-13
PT1485090E (pt) 2008-01-14
HUP0500092A2 (hu) 2005-04-28
NZ535081A (en) 2007-05-31
CA2478223C (en) 2012-05-15
CN1939299A (zh) 2007-04-04
DE60316775T2 (de) 2008-04-30
AU2003223958A1 (en) 2003-09-22
DE60316775D1 (de) 2007-11-22
CA2478223A1 (en) 2003-09-18
CY1107126T1 (el) 2012-10-24
AU2003223958B2 (en) 2007-04-19
RU2341260C2 (ru) 2008-12-20
EP1485090B1 (en) 2007-10-10
NO20044208L (no) 2004-10-14
ES2295575T3 (es) 2008-04-16
JP2005522461A (ja) 2005-07-28
CN100402029C (zh) 2008-07-16
DK1485090T3 (da) 2008-02-04
HK1072723A1 (en) 2005-09-09
NO20044208D0 (no) 2004-10-04
EP1485090A2 (en) 2004-12-15
KR20040101274A (ko) 2004-12-02
CN1638767A (zh) 2005-07-13

Similar Documents

Publication Publication Date Title
BG106585A (en) Kinase inhibitors as therapeutic agents
MY138352A (en) Benzothiazole derivatives
ATE302775T1 (de) Carbolinderivate
WO2006028958A3 (en) Pyridyl inhibitors of hedgehog signalling
AU2002314914A1 (en) Hydroxy alkyl amine derivatives as beta-secretase inhibitors and their use for the treatment of alzheimer's disease and similar diseases
TW200420549A (en) Thiazole derivatives
ZA200604114B (en) Use of substituted 2-aminotetralines for the preventative treatment of parkinson's disease
DE60216233D1 (en) Carbolinderivate
PL363363A1 (pl) Pochodne epotilonu do leczenia opornych guzów
WO2004014869A3 (en) 5,6-fused 3,4-dihydropyrimidine-2-one derivatives as matrix metalloproteinase inhibitors
MXPA05006889A (es) Compuestos aromaticos como agentes anti-inflamatorios, inmunomoduladores y anti-proliferativos.
BR0305708A (pt) Derivados de benzimidazol para o tratamento de disfunção sexual
IL188859A0 (en) Combinations comprising epothilone derivatives and alkylating agents
MXPA04000567A (es) COMBINACIONES QUE COMPRENDEN EPOTILONAS Y SUS USOS FARMACeUTICOS.
PL370322A1 (pl) Zastosowanie pochodnych 2-amino-4-heteroaryloetylotiazoliny jako inhibitorów indukcyjnej syntazy NO
MXPA03004023A (es) Compuestos quimicos.
BR0200536A (pt) Compostos de sulfonilpiridazinana úteis como inibidores de aldose reductase
IL161275A (en) [[2-(amino-3,4-dioxo-1cyclobuten-1-yl)amino]alkyl] -acid derivatives for the treatment of pain
TW200634013A (en) Quinoline derivative, its use, production and pharmaceutical agents containing the derivative
WO2004044174A3 (en) Topoisomerase-targeting agents
EP1854464A3 (en) Combinations comprising epothilone derivatives and alkylating agents
MY148416A (en) Amine salt of carbostyril derivative
PL1605937T3 (pl) Leczenie chorób proliferacyjnych pochodnymi epotilonu i promieniowaniem
SI1553938T1 (sl) Uporaba epotilonskih derivatov za zdravljenje hiperparatiroidizma
ZA200400824B (en) Pyridin-2-yl-methlyamine derivatives for treating opioid dependence.

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)